ASML

1,115.2

+0.94%↑

SAP

147.14

+0.41%↑

IFX

37.93

+1.91%↑

NOKIA.FI

6.79

-2.58%↓

STMPA.FR

28.61

+2.47%↑

ASML

1,115.2

+0.94%↑

SAP

147.14

+0.41%↑

IFX

37.93

+1.91%↑

NOKIA.FI

6.79

-2.58%↓

STMPA.FR

28.61

+2.47%↑

ASML

1,115.2

+0.94%↑

SAP

147.14

+0.41%↑

IFX

37.93

+1.91%↑

NOKIA.FI

6.79

-2.58%↓

STMPA.FR

28.61

+2.47%↑

ASML

1,115.2

+0.94%↑

SAP

147.14

+0.41%↑

IFX

37.93

+1.91%↑

NOKIA.FI

6.79

-2.58%↓

STMPA.FR

28.61

+2.47%↑

ASML

1,115.2

+0.94%↑

SAP

147.14

+0.41%↑

IFX

37.93

+1.91%↑

NOKIA.FI

6.79

-2.58%↓

STMPA.FR

28.61

+2.47%↑

Kodu・Aktsiate loetelu・Claranova SE

Claranova SE

Suletud

1.042

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.042

Max

1.042

Põhinäitajad
By Trading Economics
Sissetulek	-37M
Müük	-176M
Kasumimarginaal	21.274
Töötajad	717
EBITDA	-17M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+271.43% upside

Turustatistika
By TradingEconomics
Turukapital	61M
Eelmine avamishind	1.04
Eelmine sulgemishind	1.042

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

2.515 / 2.61 Toetus ja vastupanu

Claranova SE Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. märts 2026, 23:31 UTC

Kuumad aktsiad

Stocks to Watch: Nike, RH, NCino

31. märts 2026, 22:35 UTC

Tulu

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1. apr 2026, 00:00 UTC

Omandamised, ülevõtmised, äriostud

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31. märts 2026, 23:50 UTC

Omandamised, ülevõtmised, äriostud

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31. märts 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31. märts 2026, 23:33 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31. märts 2026, 23:21 UTC

Tulu

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31. märts 2026, 23:14 UTC

Market Talk

Tulu

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31. märts 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss Widens >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31. märts 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31. märts 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31. märts 2026, 21:35 UTC

Tulu

Nike Expects China Sales Down 20% in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31. märts 2026, 21:33 UTC

Omandamised, ülevõtmised, äriostud

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31. märts 2026, 21:33 UTC

Tulu

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31. märts 2026, 21:32 UTC

Tulu

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31. märts 2026, 21:28 UTC

Tulu

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31. märts 2026, 21:26 UTC

Tulu

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31. märts 2026, 21:25 UTC

Tulu

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31. märts 2026, 21:24 UTC

Market Talk

Tulu

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31. märts 2026, 21:22 UTC

Tulu

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31. märts 2026, 21:22 UTC

Tulu

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31. märts 2026, 21:21 UTC

Tulu

Nike's Digital Channel Still Too Promotional, CFO Says

31. märts 2026, 21:20 UTC

Tulu

Nike CEO: Converse Remains Important to Portfolio

Võrdlus sarnastega

Hinnamuutus

Claranova SE Prognoos

Hinnasiht

By TipRanks

271.43% tõus

12 kuu keskmine prognoos

Keskmine 2.6 EUR 271.43%

Kõrge 2.6 EUR

Madal 2.6 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi Claranova SE 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Claranova SE aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.515 / 2.61Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bullish.

Finantsandmed

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Claranova SE

Claranova SE, a technology company, engages in personalized e-commerce, software publishing, and internet of things (IoT) management in France, the United States, the United Kingdom, Germany, other European countries, and internationally. It operates in three segments: PlanetArt, Avanquest, and myDevices. The PlanetArt segment offers photos, frames, personalized books, and FreePrints mobile applications. The Avanquest segment provides antivirus, ad blocker, cleaning, and optimization tools under the Adaware brand; document management tools under the SodaPDF brand; and photo editor software and applications developed under the inPixio brand. The myDevices segment offers IoT solutions. Claranova SE was incorporated in 1984 and is headquartered in Courbevoie, France.